HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes.

AbstractBACKGROUND:
Angiopoietin-like protein 4 (ANGPTL4) has been identified as an inhibitor of lipoprotein lipase. Preliminary data suggest that plasma nonesterified fatty acids (NEFAs) raise plasma ANGPTL4 concentrations in humans.
OBJECTIVE:
The objective was to assess plasma ANGPTL4 concentrations after various nutritional interventions that increase NEFA concentrations in healthy subjects and in patients with type 2 diabetes mellitus.
DESIGN:
We studied 4 groups, both at baseline and after 3 d of either fasting (n = 22 healthy men), a very-low-calorie diet (VLCD; n = 10 healthy men and n = 10 patients with diabetes), or a high-fat, high-energy diet (HFED; n = 15 healthy men). Plasma ANGPTL4, NEFA, and triglyceride concentrations were measured.
RESULTS:
In healthy men, a VLCD increased ANGPTL4 from 13.2 (IQR: 8.1-24.2) at baseline to 18.2 (16.7-33.4) ng/mL (P < 0.05), fasting increased ANGPTL4 from 10.6 (7.6-17.6) to 28.0 (23.1-35.0) ng/mL (P < 0.05), and an HFED increased ANGPTL4 from 13.9 (8.2-22.0) to 17.2 (11.2-23.6) ng/mL (P < 0.05). In men with diabetes, a VLCD also increased ANGPTL4, from 10.9 ± 2.4 to 19.2 ± 3.2 ng/mL (P < 0.05). All interventions significantly increased plasma NEFAs in both healthy men and patients with diabetes. The change in ANGPTL4 positively correlated with the change in NEFA concentrations (β = 0.048, P < 0.001) and negatively correlated with the change in plasma triglycerides (β = -0.051, P = 0.01).
CONCLUSIONS:
Three days of either fasting, a VLCD, or an HFED increased plasma ANGPTL4 concentrations in healthy men, concomitantly with increased plasma NEFA concentrations. Similarly, a VLCD in patients with diabetes increased ANGPTL4 concentrations, concomitantly with increased NEFA concentrations.
AuthorsJacqueline T Jonker, Johannes W A Smit, Sebastiaan Hammer, Marieke Snel, Rutger W van der Meer, Hildo J Lamb, Frits Mattijssen, Karin Mudde, Ingrid M Jazet, Olaf M Dekkers, Albert de Roos, Johannes A Romijn, Sander Kersten, Patrick C N Rensen
JournalThe American journal of clinical nutrition (Am J Clin Nutr) Vol. 97 Issue 2 Pg. 255-60 (Feb 2013) ISSN: 1938-3207 [Electronic] United States
PMID23283507 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ANGPTL4 protein, human
  • Angiopoietin-Like Protein 4
  • Angiopoietins
  • Fatty Acids, Nonesterified
  • Triglycerides
Topics
  • Adult
  • Angiopoietin-Like Protein 4
  • Angiopoietins (blood)
  • Caloric Restriction
  • Diabetes Mellitus, Type 2 (blood, diet therapy)
  • Diet, High-Fat (adverse effects)
  • Energy Intake
  • Enzyme-Linked Immunosorbent Assay
  • Fasting (adverse effects)
  • Fatty Acids, Nonesterified (blood)
  • Humans
  • Male
  • Middle Aged
  • Triglycerides (blood)
  • Up-Regulation
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: